Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 42Leukemia 34Lymphoma, Large B-Cell, Diffuse 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Leukemia, Myeloid, Acute 24Burkitt Lymphoma 19Leukemia, Myelomonocytic, Acute 16Lung Neoplasms 15Leukemia, Monocytic, Acute 15Neuroblastoma 14Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Lymphoma, Non-Hodgkin 13Lymphoma, Follicular 13Hodgkin Disease 12Congenital Abnormalities 12Carcinoma, Non-Small-Cell Lung 12Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Mantle-Cell 10Central Nervous System Neoplasms 10Sarcoma 9Myelodysplastic Syndromes 9Anemia, Refractory, with Excess of Blasts 8Small Cell Lung Carcinoma 7Myeloproliferative Disorders 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Lymphocytic, Chronic, B-Cell 7Testicular Neoplasms 6Multiple Myeloma 6Lymphoma, B-Cell, Marginal Zone 6

Interventions

Trastuzumab 2Paclitaxel 2Leucovorin 2Fluorouracil 2Carboplatin 2veliparib 1tipifarnib 1entinostat 1Vincristine 1Taxes 1Semaxinib 1Oxaliplatin 1Interleukin-12 Subunit p35 1Interleukin-12 1Floxuridine 1Etoposide 1Epirubicin 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neoplasms, Unknown Primary × Etoposide × Clear all
NCT00003558 2013-08-07

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

National Cancer Institute (NCI)

Phase 3 Unknown
140 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡